Zhao, Bing
Sun, Wenwu
Wang, Yihui
Ma, Li
Gui, Menglu
Li, Jiaoyan
Yu, Xianxian
Qi, Xing
Ning, Ning
Sun, Silei
Li, Mengjiao
Yao, Yi
Ni, Tongtian
He, Juan
Yang, Zhitao
Chen, Ying
Sheng, Huiqiu
Shen, Meihua
Li, Jian
Huang, Jun
Mao, Enqiang https://orcid.org/0000-0002-2935-0691
Funding for this research was provided by:
Shanghai Municipal Science and Technology Commission (18411966400)
National Natural Science Foundation of China (81870311)
Shanghai Natural Science Fund (21ZR1440400)
Clinical Research Project of Ruijin Hospital Affiliated to Shanghai Jiao Tong University School of Medicine (2018CR004)
the Project of Shanghai Science and Technology Commission (22Y11900300)
the Project of China Primary Health Care Foundation (MTP2022A0132)
the Project of Shanghai Administration of Traditional Chinese Medicine (ZXXT-202213)
Article History
Received: 21 September 2024
Accepted: 13 January 2025
First Online: 17 March 2025
Declarations
:
: This randomized, placebo-controlled trial was conducted at a single center and was approved by the institutional ethics board of Ruijin Hospital, Shanghai Jiao Tong University School of Medicine (registration number: 2019-90). The patients were included, after information and signed informed consents. Oversight and study approval were provided by the Chinese Clinical Trial Registry (ChiCTR) on March 21, 2019.
: Yes.
: The authors report no conflicts of interest in this work.